← Back to Search

Carotenoid Measurements for Macular Pigmentation

N/A

Recruiting

Led By Paul Bernstein, MD, PhD

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients with adult vitelliform dystrophy. (This condition initially presents in adulthood as bilateral subtle and often asymptomatic macular lesions, which are often misdiagnosed as early age-related macular degeneration (AMD)).

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at enrollment

Awards & highlights

Study Summary

This trial will help scientists understand the role of nutrition in eye and other tissue health. They will do this by measuring carotenoids in different ways and seeing how well those measurements match up.

Who is the study for?

This trial is for anyone aged 7 or older who's getting a routine eye exam at the Moran Eye Center. It includes those with adult vitelliform dystrophy, which can look like early age-related macular degeneration but starts in adulthood.Check my eligibility

What is being tested?

The study aims to understand how nutrition affects our eyes and skin by testing non-invasive ways to measure carotenoid levels in these tissues. Part of the study also looks at carotenoid levels in blood samples from some participants.See study design

What are the potential side effects?

Since this trial involves non-invasive measurements rather than medication or invasive procedures, there are no direct side effects associated with the interventions being studied.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with adult vitelliform dystrophy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and at enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Carotenoid levels in the eye

Carotenoid levels in the skin

Secondary outcome measures

Carotenoid levels in the blood

Trial Design

1Treatment groups

Experimental Treatment

Group I: Carotenoid measurementsExperimental Treatment1 Intervention

Subjects are asked to have carotenoid levels measured in the eye, skin and/or blood.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor

1,099 Previous Clinical Trials

1,768,689 Total Patients Enrolled

Paul Bernstein, MD, PhDPrincipal InvestigatorUniversity of Utah Moran Eye Center

2 Previous Clinical Trials

145 Total Patients Enrolled

Media Library

Carotenoid measurements Clinical Trial Eligibility Overview. Trial Name: NCT03022773 — N/A

Macular Pigmentation Research Study Groups: Carotenoid measurements

Macular Pigmentation Clinical Trial 2023: Carotenoid measurements Highlights & Side Effects. Trial Name: NCT03022773 — N/A

Carotenoid measurements 2023 Treatment Timeline for Medical Study. Trial Name: NCT03022773 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently accepting participants for this trial?

"Yes, the facts on clinicaltrials.gov authenticate that this medical trial is currently searching for participants. The research was initially publicized on June 1st 2015 and has been refreshed as of November 3rd 2022. A total of 10,000 patients from a single site are needed to fulfil the recruitment goals."

Answered by AI

To what extent has participation in this experiment grown?

"Affirmative, clinicaltrials.gov confirms that this medical trial is recruiting at present. It was first announced on June 1st 2015 and the latest update occurred November 3rd 2022. The aim is to admit 10,000 patients from a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Macular Pigment Measurements in Eye & Other Tissues

Paul S. Bernstein 2015. "Macular Pigment Measurements in Eye & Other Tissues". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03022773.

All > Utah